Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager
Ascendis Pharma A/S Logo
Ascendis Pharma A/S
NASDAQ:ASND
Watchlist
Price: 126.03 USD -1.28% Market Closed
Market Cap: 7.2B USD
Have any thoughts about
Ascendis Pharma A/S?
Write Note

Ascendis Pharma A/S
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ascendis Pharma A/S
Net Income (Common) Peer Comparison

Comparables:
GMAB
ZEAL
B
BAVA
F
FLUO
BIOPOR

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Ascendis Pharma A/S
NASDAQ:ASND
Net Income (Common)
-€489.5m
CAGR 3-Years
-2%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Genmab A/S
CSE:GMAB
Net Income (Common)
kr5.5B
CAGR 3-Years
30%
CAGR 5-Years
36%
CAGR 10-Years
45%
Zealand Pharma A/S
CSE:ZEAL
Net Income (Common)
-kr1.1B
CAGR 3-Years
2%
CAGR 5-Years
-16%
CAGR 10-Years
-37%
B
Bavarian Nordic A/S
CSE:BAVA
Net Income (Common)
kr707.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
F
Fluoguide AS
STO:FLUO
Net Income (Common)
-kr38.4m
CAGR 3-Years
-30%
CAGR 5-Years
-273%
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Net Income (Common)
-kr50m
CAGR 3-Years
6%
CAGR 5-Years
0%
CAGR 10-Years
-10%

See Also

What is Ascendis Pharma A/S's Net Income (Common)?
Net Income (Common)
-489.5m EUR

Based on the financial report for Jun 30, 2024, Ascendis Pharma A/S's Net Income (Common) amounts to -489.5m EUR.

What is Ascendis Pharma A/S's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-22%

Over the last year, the Net Income (Common) growth was 20%. The average annual Net Income (Common) growth rates for Ascendis Pharma A/S have been -2% over the past three years , -22% over the past five years .

Back to Top